Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
P.DongL.ZhangZ
MASH improvement (no fibrosis worsening) at 2.4mg: 47% MASH improvement (no fibrosis worsening) at 4.8mg: 62% MASH improvement (no fibrosis worsening) at 6.0mg: 43% Placebo MASH improvement: 14% Liver fat reduction of 30%+ at 4.8mg: 67% Fibrosis improvement by 1+ stage: 34-36% These results led to FDA Breakthrough Therapy designation, which accelerates the development and review process for drugs addressing serious conditions
Both interact with similar biological processes, but BPC-157 offers higher purity and shelf stability for research use
First, determine the volume of bacteriostatic water to add using the free PSPeptides reconstitution calculator
Clinical Update 3/17/2025 More Xylitol Controversy Xylitol was linked with possible increased risk of heart-related adverse events in 2024, but a recent commentary questioned the link
US$ 20.24
US$ 25.42
US$ 27.64
US$ 28.22
